1
|
Nabovati E, Farzandipour M, Sadeghi M, Sarrafzadegan N, Noohi F, Sadeqi Jabali M. A Global Overview of Acute Coronary Syndrome Registries: A Systematic Review. Curr Probl Cardiol 2023; 48:101049. [PMID: 34780868 DOI: 10.1016/j.cpcardiol.2021.101049] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2021] [Accepted: 11/05/2021] [Indexed: 12/16/2022]
Abstract
The present study was conducted with the aim of identifying, and summarizing the characteristics of ACS registries at national, multinational and international levels. Literature was searched using keywords in the title and/or abstract without any time limit ending in March, 2021. After excluding duplicates, 2 reviewers independently reviewed the titles and/or abstracts and full text for inclusion. Each reviewer independently extracted the characteristics of the registries from included papers. Finally, the extracted characteristics were confirmed by a second reviewer. Out of the 1309 papers included, 71 ACS registries were identified (including 60 national and 11 multinational and international registries). Most national registries were being used in Europe. Most registries focused on measuring quality. In more than half of the registries, all types of ACS patients were enrolled. The diagnostic and drug classification systems were mentioned in eight and five registries, respectively. The design of 55 registries was hospital-based. The ability of computerized audit checks was made for 34 registries. More than half of the registries had patient consent and had a web-based design. In all the ACS registries, patient characteristics, clinical characteristics and treatment characteristics were recorded and post-discharge follow-up information was recorded in 45 registries. In the current situation and given that a limited number of countries in the world have national ACS registries, reviewing the results of this study and modeling the registries implemented in the leading countries can help countries without a registry to design it.
Collapse
Affiliation(s)
- Ehsan Nabovati
- Health Information Management Research Center, Department of Health Information Management and Technology, Kashan University of Medical Sciences, Kashan, Iran
| | - Mehrdad Farzandipour
- Health Information Management Research Center, Department of Health Information Management and Technology, Kashan University of Medical Sciences, Kashan, Iran.
| | - Masoumeh Sadeghi
- Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Nizal Sarrafzadegan
- Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Feridoun Noohi
- Iranian Network of Cardiovascular Research, Iran; Cardiovascular Intervention Research Center, Shaheed Rajaie Cardiovascular Medical and Research Center, Tehran, Iran
| | - Monireh Sadeqi Jabali
- Health Information Management Research Center, Department of Health Information Management and Technology, Kashan University of Medical Sciences, Kashan, Iran.
| |
Collapse
|
2
|
Ludman P, Zeymer U, Danchin N, Kala P, Laroche C, Sadeghi M, Caporale R, Shaheen SM, Legutko J, Iakobishvili Z, Alhabib KF, Motovska Z, Studencan M, Mimoso J, Becker D, Alexopoulos D, Kereseselidze Z, Stojkovic S, Zelveian P, Goda A, Mirrakhimov E, Bajraktari G, Farhan HA, Šerpytis P, Raungaard B, Marandi T, Moore AM, Quinn M, Karjalainen PP, Tatu-Chitoiu G, Gale CP, Maggioni AP, Weidinger F. Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients. EUROPEAN HEART JOURNAL. ACUTE CARDIOVASCULAR CARE 2023; 12:22-37. [PMID: 36346109 DOI: 10.1093/ehjacc/zuac143] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Revised: 09/28/2022] [Accepted: 11/04/2022] [Indexed: 11/10/2022]
Abstract
AIMS To use quality indicators to study the management of ST-segment elevation myocardial infarction (STEMI) in different regions. METHODS AND RESULTS Prospective cohort study of STEMI within 24 h of symptom onset (11 462 patients, 196 centres, 26 European Society of Cardiology members, and 3 affiliated countries). The median delay between arrival at a percutaneous cardiovascular intervention (PCI) centre and primary PCI was 40 min (interquartile range 20-74) with 65.8% receiving PCI within guideline recommendation of 60 min. A third of patients (33.2%) required transfer from their initial hospital to one that could perform emergency PCI for whom only 27.2% were treated within the quality indicator recommendation of 120 min. Radial access was used in 56.6% of all primary PCI, but with large geographic variation, from 76.4 to 9.1%. Statins were prescribed at discharge to 98.7% of patients, with little geographic variation. Of patients with a history of heart failure or a documented left ventricular ejection fraction ≤40%, 84.0% were discharged on an angiotensin-converting enzyme inhibitor/angiotensin receptor blocker and 88.7% were discharged on beta-blockers. CONCLUSION Care for STEMI shows wide geographic variation in the receipt of timely primary PCI, and is in contrast with the more uniform delivery of guideline-recommended pharmacotherapies at time of hospital discharge.
Collapse
Affiliation(s)
- Peter Ludman
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
| | - Uwe Zeymer
- Klinikum der Stadt Ludwigshafen and Institut für Herzinfarktforschung, Ludwigshafen am Rhein, Germany
| | - Nicolas Danchin
- Hôpital Européen Georges Pompidou, Service de Cardiologie Paris, Paris, France
| | - Petr Kala
- Department of Internal Medicine and Cardiology, Medical Faculty of Masaryk University, University Hospital Brno, Brno, Czech Republic
| | - Cécile Laroche
- EURObservational Research Programme, European Society of Cardiology, Sophia Antipolis, France
| | - Masoumeh Sadeghi
- Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Roberto Caporale
- Interventional Cardiology Unit, Annunziata Civil Hospital, Cosenza, Italy
| | | | - Jacek Legutko
- Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland
| | | | - Khalid F Alhabib
- Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - Zuzana Motovska
- Cardiocenter, Third Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
| | - Martin Studencan
- Cardiocentre Presov, Teaching Hospital of J.A. Reiman, Presov, Slovakia
| | - Jorge Mimoso
- Centro Hospitalar e Universitário do Algarve, Faro, Portugal
| | - David Becker
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Dimitrios Alexopoulos
- National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece
| | | | - Sinisa Stojkovic
- Faculty of Medicine, University of Belgrade, Belgrade, Serbia.,Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia
| | - Parounak Zelveian
- Scientific Research Institute of Cardiology named after Levon Hovhannisyan, Yerevan, Armenia
| | - Artan Goda
- Cardiology I and Cardiology II, University Hospital Center Mother Theresa, Tirana, Albania
| | - Erkin Mirrakhimov
- Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan.,National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
| | - Gani Bajraktari
- Medical Faculty, University of Prishtina 'Hasan Prishtina', University Clinical Centre of Kosova, Prishtina, Kosovo
| | - Hasan Ali Farhan
- Iraqi Board for Medical Specializations, Scientific Council of Cardiology, Baghdad Heart Centre, Medical City, Baghdad, Iraq
| | | | - Bent Raungaard
- Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
| | - Toomas Marandi
- Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia.,Department of Cardiology, University of Tartu, Tartu, Estonia
| | | | - Martin Quinn
- St Vincent's University Hospital, Dublin 4, Ireland
| | - Pasi Paavo Karjalainen
- Heart and Lung Center, Helsinki University Hospital and Helsinki University, Helsinki, Finland
| | | | - Chris P Gale
- EURObservational Research Programme, European Society of Cardiology, Sophia Antipolis, France.,Department of Cardiology, Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - Aldo P Maggioni
- EURObservational Research Programme, European Society of Cardiology, Sophia Antipolis, France.,ANMCO Research Center, Heart Care Foundation, Florence, Italy
| | | | | |
Collapse
|
3
|
Zeymer U, Ludman P, Danchin N, Kala P, Laroche C, Gale CP, Maggioni AP, Siabani S, Sadeghi M, Wafa A, Bartus S, Weidinger F. Reperfusion therapy for ST-elevation myocardial infarction complicated by cardiogenic shock: the European Society of Cardiology EurObservational programme acute cardiovascular care-European association of PCI ST-elevation myocardial infarction registry. EUROPEAN HEART JOURNAL. ACUTE CARDIOVASCULAR CARE 2022; 11:481-490. [PMID: 35593654 DOI: 10.1093/ehjacc/zuac049] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/02/2021] [Revised: 04/12/2022] [Accepted: 04/19/2022] [Indexed: 06/15/2023]
Abstract
AIMS To determine the current state of the use of reperfusion and adjunctive therapies and in-hospital outcomes in European Society of Cardiology (ESC) member and affiliated countries for patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock (CS). METHODS AND RESULTS ESC EurObservational Research Programme prospective international cohort study of admissions with STEMI within 24 h of symptom onset (196 centres; 26 ESC member and 3 affiliated countries). Of 11 462 patients enrolled, 448 (3.9%) had CS. Patients with compared to patients without CS, less frequently received primary percutaneous coronary intervention (PCI) (65.5% vs. 72.2%) and fibrinolysis (15.9% vs. 19.0), and more often had no reperfusion therapy (19.0% vs. 8.5%). Mechanical support devices (intraaortic ballon pump 11.2%, extracoporeal membrane oxygenation 0.7%, other 1.1%) were used infrequently in CS. Bleeding definition academic research consortium 2-5 bleeding complications (10.1% vs. 3.0%, P < 0.01) and stroke (4.2% vs. 0.9%, P < 0.01) occurred more frequently in patients with CS. In-hospital mortality was 10-fold higher (35.5% vs. 3.1%) in patients with CS. Mortality in patients with CS in the groups with PCI, fibrinolysis, and no reperfusion therapy were 27.4%, 36.6%, and 62.4%, respectively. CONCLUSION In this multi-national registry, patients with STEMI complicated by CS less frequently receive reperfusion therapy than patients with STEMI without CS. Early mortality in patients with CS not treated with primary PCI is very high. Therefore, strategies to improve clinical outcome in STEMI with CS are needed.
Collapse
Affiliation(s)
- Uwe Zeymer
- Klinikum der Stadt Ludwigshafen and Institut für Herzinfarktforschung, Ludwigshafen am Rhein, Germany
| | - Peter Ludman
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
| | - Nicolas Danchin
- Hôpital Européen G. Pompidou, Service de Cardiologie, Paris, France
| | - Petr Kala
- Internal Cardiology Department, Faculty of Medicine of Masaryk University, University Hospital Brno, Brno, Czech Republic
| | - Cécile Laroche
- EURObservational Research Program, European Society of Cardiology, Sophia-Antipolis, France
| | - Chris P Gale
- Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK
| | - Aldo P Maggioni
- EURObservational Research Program, European Society of Cardiology, Sophia-Antipolis, France
- Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy
| | - Soraya Siabani
- Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Masoumeh Sadeghi
- Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Ahmed Wafa
- Mansoura Faculty of Medicine, Cardiology department, Mansoura, Egypt
| | - Stanislaw Bartus
- Department of Cardiology, Jagiellonian University, Krakow, Poland
| | | |
Collapse
|
4
|
Abstract
Purpose of this Review We discuss the role of observational studies and cardiac registries during the COVID-19 pandemic. We focus on published cardiac registries and highlight contributions to the field that have had clinical implications. Recent Findings We included observational studies of COVID-19 patients published in peer-reviewed medical journals with defined inclusion and exclusion criteria, defined study design, and primary outcomes. A PubMed and MEDLINE literature review results in 437 articles, of which 52 include patients with COVID-19 with cardiac endpoints. From July 2020 to December 2021, the average time from last data collected to publication was 8.9 ± 4.1 months, with an increasing trend over time (R = 0.9444, p < 0.0001). Of the 52 articles that met our inclusion criteria, we summarize main findings of 4 manuscripts on stroke, 14 on acute coronary syndrome, 4 on cardiac arrest, 7 on heart failure, 7 on venous thromboembolism, 5 on dysrhythmia, and 11 on different populations at risk for cardiovascular. Summary Registries are cost effective, not disruptive to essential health services, and can be rapidly disseminated with short intervals between last data point collected and publication. In less than 2 years, cardiac registries have filled important gaps in knowledge and informed the care of COVID-19 patients with cardiovascular conditions. Supplementary Information The online version contains supplementary material available at 10.1007/s11886-022-01686-5.
Collapse
|
5
|
Kanakakis I, Stafylas P, Tsigkas G, Nikas D, Synetos A, Avramidis D, Tsiafoutis I, Dagre A, Tzikas S, Latsios G, Patsourakos N, Sanidas I, Skalidis E, Pipilis A, Bamidis P, Davlouros P, Kanakakis I, Tselegkidi M, Sertedaki E, Mamarelis I, Fraggos E, Mantzouranis E, Karvounis C, Manolis A, Chatzilymperis G, Chiotelis I, Gryllis D, Poulimenos L, Triantafyllis A, Alexopoulos D, Varlamos C, Almpanis G, Aggeli A, Sakkas A, Trikas A, Tsiamis S, Triantafylloy K, Mpenia D, Oikonomou D, Papadopoulou E, Avramidis D, Kousta M, Moulianitaki E, Poulianitis G, Mavrou G, Latsios G, Synetos A, Tousoulis D, Kafkas N, Godwin S, Mertzanos G, Koytouzis M, Tsiafoutis I, Papadopoulos A, Tsoumeleas A, Barbetseas I, Sanidas I, Athanasiou A, Paizis I, Kakkavas A, Papafanis T, Mantas I, Neroutsos G, Gkoliopoulou A, Tafrali V, Diakakis G, Grammatikopoulos K, Sinanis T, Kartalis A, Afendoulis D, Voutas P, Kardamis C, Doulis A, Kalantzis N, Vergis K, Chasikidis C, Armatas G, Damelou A, Ntogka M, Serafetinidis I, Zagkas K, Tselempis T, Makridis P, Karantoumanis I, Karapatsoudi E, Oikonomou K, Foukarakis E, Kafarakis P, Pitarokoilis M, Rogdakis E, Stavrakis S, Koudounis G, Karampetsos V, Lionakis N, Panotopoulos C, Svoronos D, Tsorlalis I, Tsatiris K, Beneki E, Papadopoulos N, Sawafta A, Kozatsani D, Spyromitros G, Bostanitis I, Dimitriadis G, Nikoloulis N, Kampouridis N, Giampatzis V, Patsilinakos S, Andrikou E, Katsiadas N, Papanagnou G, Kotsakis A, Ioannidis E, Platogiannis N, Psychari S, Pissimissis E, Gavrielatos G, Maritsa D, Papakonstantinou N, Patsourakos N, Oikonomou G, Katsanou K, Lazaris E, Moschos N, Giakoumakis T, Papagiannis N, Goudis C, Daios S, Devliotis K, Dimitriadis F, Giannadaki M, Savvidis M, Tsinopoulos G, Zarifis I, Askalidou T, Vasileiadis I, Kleitsiotou P, Sidiropoulos S, Tsaousidis A, Tzikas S, Vassilikos V, Papadopoulos C, Zarvalis Ε, Gogos C, Moschovidis V, Styliadis I, Laschos V, Spathoulas K, Vogiatzis I, Kasmeridis C, Papadopoulos A, Pittas S, Sdogkos E, Dagre A, Mpounas P, Rodis I, Pipilis A, Konstantinidis S, Makrygiannis S, Masdrakis A, Magginas A, Sevastos G, Katsimagklis G, Skalidis E, Petousis S, Davlouros P, Tsigkas G, Hahalis G, Koufou E, Tziakas D, Chalikias G, Thomaidi A, Stakos D, Chotidis A, Nikas D, Sakellariou X, Skoularigkis I, Dimos A, Iakovis N, Mpourazana A, Zagouras A, Lygkouri G, Bamidis P, Lagakis P, Spachos D, Stafylas P, Chalitsios C, Karaiskou M, Tychala C. Epidemiology, reperfusion management and outcomes of patients with myocardial infarction in Greece: The ILIAKTIS study. Hellenic J Cardiol 2022; 67:1-8. [DOI: 10.1016/j.hjc.2022.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Revised: 01/20/2022] [Accepted: 03/08/2022] [Indexed: 11/26/2022] Open
|
6
|
Zeymer U, Ludman P, Danchin N, Kala P, Laroche C, Sadeghi M, Caporale R, Shaheen SM, Legutko J, Iakobsishvili Z, Alhabib KF, Motovska Z, Studencan M, Mimoso J, Becker D, Alexopoulos D, Kereseselidze Z, Stojkovic S, Zelveian P, Goda A, Mirrakhimov E, Bajraktari G, Al-Farhan H, Šerpytis P, Raungaard B, Marandi T, Moore AM, Quinn M, Karjalainen PP, Tatu-Chitolu G, Gale CP, Maggioni AP, Weidinger F. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology. Eur Heart J 2021; 42:4536-4549. [PMID: 34389857 DOI: 10.1093/eurheartj/ehab342] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 04/18/2021] [Accepted: 06/05/2021] [Indexed: 02/05/2023] Open
Abstract
AIMS The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). METHODS AND RESULTS Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5-5.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8-97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1-70.1%) for timely reperfusion. CONCLUSIONS The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality.
Collapse
Affiliation(s)
- Uwe Zeymer
- Klinikum der Stadt Ludwigshafen and Institut für Herzinfarktforschung, Bremserstraße 79, 67063 Ludwigshafen am Rhein, Germany
| | - Peter Ludman
- Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston 1, Birmingham, B15 2TT, United Kingdom
| | - Nicolas Danchin
- Hôpital Européen Georges Pompidou, Service de Cardiologie, 20 Rue Leblanc, 75015 Paris, France
| | - Petr Kala
- University Hospital Brno, Medical Faculty of Masaryk University, Dept of Internal Medicine and Cardiology, Kamenice 5, 625 00 Bohunice, Brno, Czech Republic
| | - Cécile Laroche
- EURObservational Research Programme, European Society of Cardiology, European Heart House, 2035 Route des Colles, Sophia Antipolis, France
| | - Masoumeh Sadeghi
- Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Shahid Rahmani Alley, Moshtagh Sevom Street, Isfahan, Iran
| | - Roberto Caporale
- Interventional Cardiology Unit, Annunziata Civil Hospital, Via Migliori 1, 87100 Cosenza, Italy
| | | | - Jacek Legutko
- Jagiellonian University Medical College; Institute of Cardiology, Department of Interventional Cardiology, John Paul II Hospital, Prądnicka 80, 31-202 Kraków, Poland
| | | | - Khalid F Alhabib
- Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - Zuzana Motovska
- Cardiocenter, Third Faculty of Medicine Charles Univ. and Univ. Hospital Kralovske Ruská 2411, 100 00 Praha 10-Vinohrady, Czech Republic
| | - Martin Studencan
- Teaching Hospital of J.A. Reiman, Cardiocentre Prešov, Jána Hollého 5898/14, 081 81 Prešov, Slovakia
| | - Jorge Mimoso
- Centro Hospitalar e Universitário do Algarve, R. Leao Penedo, 8000-386 Faro, Portugal
| | - David Becker
- Deputy-Director of the Heart and Vascular Center of Semmelweis University, Gaál József út 9, 1122 Budapest, Hungary
| | - Dimitrios Alexopoulos
- National and Kapodistrian University of Athens, Attikon University Hospital, Rimini 1, Chaidari 124 62, Greece
| | - Zviad Kereseselidze
- Chapidze Emergency Cardiology Center, 0159, Didube-Chugureti District, Nino Javakhishvili str., Tbilisi, Georgia
| | - Sinisa Stojkovic
- Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Department of Cardiology, Clinical Center of Serbia, Pasterova 2, Beograd 11000 Belgrade, Serbia
| | - Parounak Zelveian
- Scientific Research Institute of Cardiology named after Levon Hovhannisyan, 0014, Yerevan, Paruyr Sevaki St., 5 Building (Kanaker-Zeytun adm. district), Yerevan, Armenia
| | - Artan Goda
- Cardiology I & Cardiology II, University Hospital Center Mother Theresa, Rruga e Dibrës 372 Tirana AL, 1000, Albania
| | - Erkin Mirrakhimov
- Kyrgyz State Medical Academy, 92 Akhunbayev St, Bishkek, Kyrgyzstan
- National Center of Cardiology and Internal Medicine, Togolok Moldo Str., 720040, Bishkek, Kyrgyzstan
| | - Gani Bajraktari
- Medical Faculty, University of Prishtina "Hasan Prishtina", University Clinical Centre of Kosova, Pristina 10000, Kosovo
| | - Hasan Al-Farhan
- Iraqi Scientific Council of Cardiology, Baghdad Heart Center, Medical City, Baghdad, Iraq
| | - Pranas Šerpytis
- Vilnius University Faculty of Medicine Hospital Santaros Klinikos, 08406, Santariškių g. 2, Vilnius 08410, Lithuania
| | - Bent Raungaard
- Aalborg University Hospital, Department of Cardiology, Hobrovej 18-22, 9100 Aalborg, Denmark
| | - Toomas Marandi
- North Estonia Medical Centre, J. Sütiste tee 19, 13419 Tallinn, Estonia
| | - Alice May Moore
- Mater Dei Hospital, Triq Dun Karm, L-Imsida, MSD2090 Msida, Malta
| | - Martin Quinn
- St Vincent's University Hospital, Merrion Rd, Dublin 4, D04 N2E0, Ireland
| | | | - Gabriel Tatu-Chitolu
- Spitalul Clinic de Urgenta "Floreasca", Calea Floreasca 8, București 014461, Romania
| | - Chris P Gale
- Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds School of Medicine, Worsley Building, University of Leeds, LS2 9JT Leeds, UK
| | - Aldo P Maggioni
- EURObservational Research Programme, European Society of Cardiology, European Heart House, 2035 Route des Colles, Sophia Antipolis, France
- Maria Cecilia Hospital, GVM Care & Research, Via Corriera, 1, 48033 Cotignola RA, Italy
| | | | | |
Collapse
|
7
|
Ibanez B, Roque D, Price S. The year in cardiovascular medicine 2020: acute coronary syndromes and intensive cardiac care. Eur Heart J 2021; 42:884-895. [PMID: 33388774 DOI: 10.1093/eurheartj/ehaa1090] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Revised: 12/07/2020] [Accepted: 12/17/2020] [Indexed: 12/21/2022] Open
Affiliation(s)
- Borja Ibanez
- Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.,Cardiology Department, IIS-Fundación Jiménez Díaz University Hospital, Madrid, Spain.,CIBERCV, Madrid, Spain
| | - David Roque
- Cardiology Department, Prof. Dr. Fernando Fonseca Hospital, Amadora, Portugal
| | - Susanna Price
- Department of Cardiology and Department of Adult Critical Care, Royal Brompton Hospital, London, UK
| |
Collapse
|
8
|
Blöndal M, Ainla T, Eha J, Lõiveke P, Marandi T, Saar A, Veldre G, Edfors R, Lewinter C, Jernberg T, Jortveit J, Halvorsen S, Becker D, Csanádi Z, Ferenci T, Andréka P, Jánosi A. Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway and Sweden according to national ongoing registries. EUROPEAN HEART JOURNAL. QUALITY OF CARE & CLINICAL OUTCOMES 2021; 8:307-314. [PMID: 33710273 DOI: 10.1093/ehjqcco/qcaa098] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 12/19/2020] [Indexed: 12/17/2022]
Abstract
AIM Describe the characteristics, management and outcomes of hospitalized ST-segment elevation myocardial infarction (STEMI) patients according to national ongoing myocardial infarction registries in Estonia, Hungary, Norway and Sweden. METHODS AND RESULTS Country-level aggregated data was used to study baseline characteristics, use of in-hospital procedures, medications at discharge, in-hospital complications, 30-day and 1-year mortality for all patients admitted with STEMI during 2014-2017 using data from EMIR (Estonia; n = 4584), HUMIR (Hungary; n = 23685), NORMI (Norway; n = 12414, data for 2013-2016) and SWEDEHEART (Sweden; n = 23342). Estonia and Hungary had a higher proportion of women, patients with hypertension, diabetes and peripheral artery disease compared to Norway and Sweden. Rates of reperfusion varied from 75.7% in Estonia to 84.0% in Sweden. Rates of recommendation of discharge medications were generally high and similar. However, Estonia demonstrated the lowest rates of dual antiplatelet therapy (78.1%) and statins (86.5%). Norway had the lowest rates of beta-blockers (80.5%) and angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (61.5%). The 30-day mortality rates ranged between 9.9-13.4% remaining lowest in Sweden. 1-year mortality rates ranged from 14.8% in Sweden and 16.0% in Norway to 20.6% in Hungary and 21.1% in Estonia. Age-adjusted lethality rates were highest for Hungary and lowest for Sweden. CONCLUSION This inter-country comparison of data from four national ongoing European registries provide new insights into the risk factors, management and outcomes of patients with STEMI. There are several possible reasons for the findings, including coverage of the registries and variability of baseline-characteristics' definitions that need to be further explored.
Collapse
Affiliation(s)
- Mai Blöndal
- Department of Cardiology, University of Tartu, 8 L. Puusepa Street, 51014, Tartu, Estonia.,Heart Clinic, Tartu University Hospital, 8 L. Puusepa Street, 51014, Tartu, Estonia
| | - Tiia Ainla
- Department of Cardiology, University of Tartu, 8 L. Puusepa Street, 51014, Tartu, Estonia.,Centre of Cardiology, North Estonia Medical Centre, 19 J. Sütiste Street, 13419, Tallinn, Estonia
| | - Jaan Eha
- Department of Cardiology, University of Tartu, 8 L. Puusepa Street, 51014, Tartu, Estonia.,Heart Clinic, Tartu University Hospital, 8 L. Puusepa Street, 51014, Tartu, Estonia
| | - Piret Lõiveke
- Department of Cardiology, University of Tartu, 8 L. Puusepa Street, 51014, Tartu, Estonia.,Centre of Cardiology, North Estonia Medical Centre, 19 J. Sütiste Street, 13419, Tallinn, Estonia
| | - Toomas Marandi
- Department of Cardiology, University of Tartu, 8 L. Puusepa Street, 51014, Tartu, Estonia.,Centre of Cardiology, North Estonia Medical Centre, 19 J. Sütiste Street, 13419, Tallinn, Estonia.,Quality Department, North Estonia Medical Centre, 19 J. Sütiste Street, 13419, Tallinn, Estonia
| | - Aet Saar
- Centre of Cardiology, North Estonia Medical Centre, 19 J. Sütiste Street, 13419, Tallinn, Estonia
| | - Gudrun Veldre
- Estonian Myocardial Infarction Registry, Tartu University Hospital, 8 L. Puusepa Street, 51014, Tartu, Estonia
| | - Robert Edfors
- Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.,Bayer AB, Solna, Sweden
| | - Christian Lewinter
- Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden
| | - Tomas Jernberg
- Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
| | - Jarle Jortveit
- Department of Cardiology, Sorlandet Hospital, Box 783, Stoa 4809, Arendal, Norway
| | - Sigrun Halvorsen
- Department of Cardiology, Oslo University Hospital, Ullevål Hospital, PB 4956, Nydalen, 0424, Oslo, Norway.,Department of Cardiology, University of Oslo, OUS HF Rikshospitalet, PB 4950, Nydalen, 0424, Oslo, Norway
| | - Dávid Becker
- Semmelweis University Heart and Vascular Center, 9 Gaál József street, Budapest, Hungary
| | - Zoltán Csanádi
- University of Debrecen, Cardiology and Heart Surgery Clinic, 22 Móricz Zsigmond street, Debrecen, Hungary
| | - Tamas Ferenci
- Obuda University, John von Neumann Faculty of Informatics, Applied Informatics Institute, Physiological Controls Group, Becsi ut 96/B, 1034, Budapest, Hungary
| | - Péter Andréka
- Gottsegen National Institute of Cardiology, Hungarian Myocardial Infarction Registry, 29 Haller street, 1096, Budapest, Hungary
| | - András Jánosi
- Gottsegen National Institute of Cardiology, Hungarian Myocardial Infarction Registry, 29 Haller street, 1096, Budapest, Hungary
| |
Collapse
|